High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer.

PLoS One · 2012 · PMC3386189 · PMID 22761906

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The results indicated that ERGIC1 silencing was able to systematically downregulate ERG mRNA expression, although the results did not reach statistical significance with both siRNAs studied (Supporting Figure S5 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.